Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from eastern China and Japan

Intervirology

Volumn 50, Issue 3, 2007, Pages 229-236

  Wang, Yun ^a,b   Kanai, Kyosuke ^a   Satoh, Yukio ^a   Luo, Bing ^b   Sairenji, Takeshi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Epstein Barr virus; Gastric carcinoma; Latent membrane protein 1; Phylogenetic tree; Polymorphism

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHINA; CONTROLLED STUDY; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; NASOPHARYNX CARCINOMA; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA;

CHINA; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; JAPAN; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; STOMACH NEOPLASMS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 34247107670     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100566     Document Type: Article

References (42)

1. Raab-Traub N: Pathogenesis of Epstein-Barr virus and its associated malignancies. Semin Virol 1996;7:315-323.
2. Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC, Wang HP, Lin JT: Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 2000;118:1031-1038.
3. Lee MA, Hong YS, Kang JH, Lee KS, You JY, Lee KY, Park CH: Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer. Korean J Intern Med 2004;19:43-47.
4. Andal N, Shanthi P, Krishnan KB, Taralaxmi V: The Epstein-Barr virus and gastric carcinoma. Indian J Pathol Microbiol 2003;46:34-36.
5. Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K: Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 1994;71:31-81.
6. Hao Z, Koriyama C, Akiba S, Li J, Luo X, Itoh T, Eizuru Y, Zou J: The Epstein-Barr virus-associated gastric carcinoma in Southern and Northern China. Oncol Rep 2002;9:1293-1298.
7. Luo B, Wang Y, Wang XF, Liang H, Yan LP, Huang BH, Zhao P: Expression of Epstein-Barr virus (EBV) in EBV-associated gastric carcinomas. World J Gastroenterol 2005;11:629-633.
8. Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E: Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993;143:1250-1254.
9. Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsuib S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM: Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes. Am J Pathol 1998;152:191-198.
10. Li HP, Chang YU: Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 2003;10:490-504.
11. Miller WE, Edwards RH, Walling DM, Raab-Traub N: Sequence variation in the Epstein-Barr virus latent membrane protein. J Gen Virol 1994;75:2729-2740.
12. Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N: Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 1999;261:79-95.
13. Dawson CW, Eliopoulos AG, Blake SM, Barker R, Young LS: Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 2000;272:204-217.
14. Fielding CA, Sandvej K, Mehl A, Brennan P, Jones M, Rowe M: Epstein-Barr virus LMP1-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J Virol 2001;75:9129-9141.
15. Cheung ST, Leung SF, Lo KW, Chiu KW, Tam JS, Fok TF, Johnson PJ, Lee JC, Huang DP: Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. In J Cancer 1998;76:399-406.
16. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS: Cloning and characterization of the latent membrane protein 1 (LMP1) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992;7:2131-2140.
17. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991;72:2399-2409.
18. Li SN, Chang YS, Liu ST: Effect of 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996;12:2129-2135.
19. Miller WE, Cheshire JL, Baldwin AS Jr, Raab-Traub N: The NPC derived C15 LMP1 protein confers enhanced activation of NFkappa B and induction of the EGFR in epithelial cells. Oncogene 1998;16:1869-1877.
20. Johnson RJ, Stack M, Hazlewood SA, Jones M, Blackmore CG, Hu LF, Rowe M: The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J Virol 1998;72:4038-4048.
21. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996;88:3491-3501.
22. Mori S, Itoh T, Tokunaga M, Eiauru Y: Deletions and single-base mutations within the carboxy-terminal region of the latent membrane protein 1 oncogene in Epstein-Barr virus-related gastric cancers of southern Japan. J Med Virol 1999;57:152-158.
23. Sandvej K, Gratama JW, Munch M, Zhou XG, Bolhuis RL, Ansresen BS, Gregersen N, Hamilton-Dutoit S: Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 1997;90:323-330.
24. Kanai K, Satoh Y, Saiki Y, Ohtani H, Sairenji T: Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1. Virus Genes 2007;34:55-61.
25. Zhang XS, Song KH, Mai HQ, Jia WH, Feng BJ, Xia JC, Zhang RH, Huang LX, Yu XJ, Feng QS, Huang P, Chen JJ, Zeng YX: The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett 2002;176:65-73.
26. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG: Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 1996;27:20-27.
27. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection proteins. Proc Natl Acad Sci USA 1994;91:9131-9135.
28. Hoshikawa Y, Satoh Y, Murakami M, Maeta M, Kaibara N, Ito H, Kurata T, Sairenji T: Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. J Med Virol 2002;66:351-359.
29. zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ: Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric carcinomas: expression of the transforming BARF1 gene. Cancer Res 2000;60:2745-2748.
30. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T: Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br J Cancer 1996;74:625-631.
31. Saitou N, Nei M: The neighbor-joining method: a new method for constructing phylogenetic trees. Mol Biol Evol 1987;4:406-425.
32. Edwards RH, Sitki-Green D, Moore DT, Raab-Traub N: Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol 2004;78:868-881.
33. Cheung ST, Lo KW, Leung SF, Chan WY, Choi PH, Johnson PJ, Lee JC, Huang DP: Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 1996;66:711-712.
34. Sung NS, Edwards RH, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, Raab-Traub N: Epstein-Barr virus strain variations in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. In J Cancer 1998;76:207-215.
35. Mainou BA, Raab-Traub: LMP1 strain variants: biological and molecular properties. J Virol 2006;80:6458-6468.
36. Burrows J, Bromham L, Woolfit M, Piaganeau G, Tellam J, Connolly G, Webb N, Poulsen L, Cooper L, Burrows S, Moss D, Haryans S, Ng M, Nicholls J, Khanna R: Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southern Asia. J Virol 2004;78:7131-7137.
37. Leung SY, Yuen ST, Chung LP, Chan ASY, Wong MP: Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane position-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. In J Cancer 1997;72:225-230.
38. Itakura O, Yamada S, Narita M, Kikuta H: High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 1996;13:1549-1553.
39. Zhou XG, Sandveij K, Li PJ, Ji XL, Yan QH, Zhang XP, Da JP, Hamilton-Dutoit SJ: Epstein-Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants. J Gen Virol 2001;82:1157-1167.
40. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I, Zeng YX: Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 2005;79:15323-15330.
41. Chang YS, Su IJ, Chung PJ, Shu CH, Ng CK, Wu SJ, Liu ST: Detection of an Epstein-Barr virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995;62:673-677.
42. De Francesco MA, Gargiulo F, Esteban P, Calzavara-Pinton PG, Venturini M, Perandin F, Baronio M, Pollara C, Terlenghi L, Manca N: Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides. J Med Microbiol 2004;53:381-387.